Jan Van den Brande

Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn's disease: a randomised controlled, open-label, multicentre trial

Cyriel Y. Ponsioen, E. Joline de Groof, Emma J. Eshuis et al. · ˜The œLancet. Gastroenterology & hepatology · 2017 · 356 citations

Medicine, Clinical Sciences, Surgery +12

Lactobacillus rhamnosus induces peripheral hyporesponsiveness in stimulated CD4+ T cells via modulation of dendritic cell function

Henri Braat, Jan Van den Brande, Erik van Tol et al. · American Journal of Clinical Nutrition · 2004 · 236 citations · Full text

Life Sciences, Immunology, Microbiology +17

Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn's disease: retrospective long-term follow-up of the LIR!C trial

Toer Stevens, Maria L. Haasnoot, Geert D’Haens et al. · ˜The œLancet. Gastroenterology & hepatology · 2020 · 179 citations

Medicine, Surgery, Gastroenterology +10

Irinotecan combined with infusional 5-fluorouracil/folinic acid or capecitabine plus celecoxib or placebo in the first-line treatment of patients with metastatic colorectal cancer. EORTC study 40015

C.-H. Köhne, Jacques De Grève, J. T. Hartmann et al. · Annals of Oncology · 2007 · 161 citations

Medicine, Oncology, Pharmacology +14

Polymorphisms Near TBX5 and GDF7 Are Associated With Increased Risk for Barrett’s Esophagus

Claire Palles, Laura Chegwidden, Xinzhong Li et al. · Gastroenterology · 2014 · 111 citations · Full text

Medicine, Genetics, Molecular Genetics +17